Literature DB >> 18535608

Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study.

M Leitritz1, F Gelisken, W Inhoffen, M Voelker, F Ziemssen.   

Abstract

BACKGROUND: Retinal pigment epithelium (RPE) tears after bevacizumab treatment for neovascular age-related macular degeneration accompanied by a pigment epithelial detachment (PED) might be caused by stretching forces on the already weakened RPE. The purpose of this study was to evaluate whether simple measurements of optical coherence tomography (OCT) can predict the individual risk of an RPE tear in preoperative candidates.
METHODS: A retrospective chart review study of 393 consecutive patients with neovascular age-related macular degeneration evaluated OCT images (Stratus-OCT Zeiss, Jena, Germany). The height of the PED, the central retinal thickness, and the maximum retinal thickness were determined by two independent observers and retrospectively analysed.
RESULTS: Fifteen patients with an RPE tear had a significant higher PED than the remaining study population. In contrast, no correlation was seen with the central retinal thickness. In a linear regression model, the probability of an RPE tear exponentially increased in dependence of the extent of PED.
CONCLUSION: The risk of an RPE tear can be estimated by simple measurement of the height of the PED on OCT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18535608     DOI: 10.1038/eye.2008.145

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  16 in total

1.  Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis).

Authors:  David Sarraf; Anthony Joseph; Ehsan Rahimy
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

2.  Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis).

Authors:  Clement K Chan; Atul Jain; Srinivas Sadda; Neeta Varshney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

3.  Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.

Authors:  Joo Youn Shin; Moonjung Choi; Byunghoon Chung; Suk Ho Byeon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-07       Impact factor: 3.117

4.  3D spectral domain OCT in spontaneous retinal pigment epithelial tear.

Authors:  Sandeep Saxena; Nibha Mishra; Carsten H Meyer
Journal:  J Ocul Biol Dis Infor       Date:  2013-04-25

5.  Retinal pigment epithelial tears following treatment in neovascular age-related macular degeneration.

Authors:  Zhi-Qing Chen; Pan-Pan Ye; Xiao-Yun Fang
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

6.  Change in vision after retinal pigment epithelium tear following the use of anti-VEGF therapy for age-related macular degeneration.

Authors:  Shane R Durkin; Lachlan D M Farmer; Susith Kulasekara; Jagjit Gilhotra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-08       Impact factor: 3.117

7.  Retinal Pigment Epithelium Tear.

Authors:  Aleksandra V Rachitskaya; Raquel Goldhardt
Journal:  Curr Ophthalmol Rep       Date:  2014-12-06

8.  Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.

Authors:  Ugo Introini; Ana Torres Gimeno; Fabrizio Scotti; Marco Setaccioli; Silvia Giatsidis; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-21       Impact factor: 3.117

Review 9.  Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

Authors:  Focke Ziemssen; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt; Martin S Spitzer
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

10.  Retinal pigment epithelial tears following ranibizumab therapy for fibrovascular retinal pigment epithelial detachment due to occult age-related macular degeneration.

Authors:  Małgorzata Figurska
Journal:  Med Sci Monit       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.